Analysis of The Cancer Genome Atlas (TCGA) database and immunohistochemistry (IHC) staining of HCC samples confirmed CKB’s upregulation in tumors, correlating high CKB phosphorylation with poorer patient survival outcomes. Here, CKB is linked to hepatocellular carcinoma.